PRPO
Precipio Achieves Historic Milestones in Q2 2025 with Record Revenues and Positive Adjusted EBITDA
In its latest quarterly shareholder update call, Precipio celebrated a slew of historic milestones, solidifying the company's position as a leader in the pathology industry. During the conference call, CEO Ilan Danieli outlined the key highlights from Q2 2025, showcasing the company's remarkable growth and resilience.